EW · 10-Q · 2026Q3 · Full report
Medicare TAVR Coverage Expansion
Edwards Lifesciences Corp · 2026-11-04 · Importance 44 · Surprise 60 · In source text
In September 2026, the Centers for Medicare & Medicaid Services updated its National Coverage Determination for transcatheter aortic valve replacement (TAVR). The change expands Medicare coverage to certain asymptomatic patients with severe aortic stenosis and reduces prior coverage restrictions for symptomatic patients. The filing does not quantify the financial impact of the coverage change.
Key facts
- In September 2026, CMS expanded Medicare TAVR coverage to certain asymptomatic severe aortic stenosis patients and reduced prior coverage restrictions for symptomatic patients. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | contingent | — | In September 2026, CMS expanded Medicare TAVR coverage to certain asymptomatic severe aortic stenosis patients and reduced prior coverage… |